In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in musculoskeletal solutions. The deal, which was initially announced in ...

Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

In the preceding three months, 5 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...